- Home
- INUV vs SCNX Comparison
INUV vs SCNX Comparison
Compare INUV & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INUV | SCNX |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 16.2M |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | INUV | SCNX |
|---|---|---|
| Price | $0.42 | $3.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 78.5K | 49.6K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $86,209,305.00 | $3,831,778.00 |
| Revenue This Year | N/A | $743.36 |
| Revenue Next Year | $12.51 | $325.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 2.88 | ★ 30.72 |
| 52 Week Low | $0.40 | $2.64 |
| 52 Week High | $3.80 | $106.25 |
Technical Indicators
Market Signals| Indicator | INUV | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 30.96 | 47.07 |
| Support Level | $0.40 | $2.64 |
| Resistance Level | $0.61 | $10.60 |
| Average True Range (ATR) | 0.03 | 0.32 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 12.71 | 49.61 |
Price Performance
Historical ComparisonAbout INUV Inuvo Inc.
Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.